Atlas Trials

A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Advanced Bone and Soft Tissue Tumors

Clinical trial NCT06171282 · UNKNOWN

Trial details

NCT number
NCT06171282
Sponsor
Shanghai Yunying Medical Technology
Status
UNKNOWN
Phase
Early Phase 1
Study type
INTERVENTIONAL
OsteosarcomaSarcomaSoft Tissue SarcomaBone Tumor
Start date
2023-07-12
Primary completion
2025-07-12
Enrollment
9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.